David Johnson brought new clinical data to the European meeting, and the main conclusion lies in the fact that we treat peritonitis badly. Mortality variability is unacceptably high in different centers. EuroPD news invited David Johnson (Australia), Dirk Vogelaer (Belgium), Matthias Eberl (Germany) and Peter Rutherford (UK) to discuss these data in the EuroPD News studio in Strasbourg.